Insights

Biotech Specialization Gubra's focus on the metabolic space including obesity, diabetes, MASH, and gastrointestinal diseases presents opportunities for collaboration with pharmaceutical companies seeking innovative solutions in these high-impact therapeutic areas.

Research Expertise With advanced capabilities in peptide chemistry, pharmacology, ex vivo assays, and bioinformatics, Gubra can serve as a strategic partner for organizations needing specialized preclinical research and early drug discovery services.

Global Partnerships Gubra works with international pharma, biotech, and academic partners, indicating potential for expansion through new collaborations aiming to leverage their scientific excellence and high-quality research outputs.

Technology Stack Utilizing diverse modern technologies such as Python, PHP, and cloud services, Gubra demonstrates a strong digital infrastructure that can support scalable research projects and offer digital solutions for clients.

Financial Range With revenue estimates between 10 to 25 million dollars, Gubra shows steady growth and potential for scaling services, making it an appealing partner for investments or joint ventures in biotech research.

Similar companies to Gubra

Gubra Tech Stack

Gubra uses 8 technology products and services including Cloudflare, Font Awesome, imagesLoaded, and more. Explore Gubra's tech stack below.

  • Cloudflare
    Content Management System
  • Font Awesome
    Font Scripts
  • imagesLoaded
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Plum
    Pre-employment Assessment
  • Python
    Programming Languages
  • PHP
    Programming Languages
  • JavaScript
    Programming Languages

Media & News

Gubra's Email Address Formats

Gubra uses at least 1 format(s):
Gubra Email FormatsExamplePercentage
FL@gubra.dkJD@gubra.dk
58%
FirLast@gubra.dkJohDoe@gubra.dk
26%
First@gubra.dkJohn@gubra.dk
9%
FiLast@gubra.dkJoDoe@gubra.dk
7%

Frequently Asked Questions

Where is Gubra's headquarters located?

Minus sign iconPlus sign icon
Gubra's main headquarters is located at Denmark. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Gubra's phone number?

Minus sign iconPlus sign icon
You can contact Gubra's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Gubra's stock symbol?

Minus sign iconPlus sign icon
Gubra is a publicly traded company; the company's stock symbol is GUBRA.CO.

What is Gubra's official website and social media links?

Minus sign iconPlus sign icon
Gubra's official website is gubra.dk and has social profiles on LinkedIn.

What is Gubra's SIC code NAICS code?

Minus sign iconPlus sign icon
Gubra's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Gubra have currently?

Minus sign iconPlus sign icon
As of April 2026, Gubra has approximately 313 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Ceo Gubra Green: V. D.Chief Technology Officer: G. G.Chief Medical And Development Officer: T. L.. Explore Gubra's employee directory with LeadIQ.

What industry does Gubra belong to?

Minus sign iconPlus sign icon
Gubra operates in the Biotechnology Research industry.

What technology does Gubra use?

Minus sign iconPlus sign icon
Gubra's tech stack includes CloudflareFont AwesomeimagesLoadedjQuery MigratePlumPythonPHPJavaScript.

What is Gubra's email format?

Minus sign iconPlus sign icon
Gubra's email format typically follows the pattern of FL@gubra.dk. Find more Gubra email formats with LeadIQ.

When was Gubra founded?

Minus sign iconPlus sign icon
Gubra was founded in 2008.

Gubra

Biotechnology ResearchDenmark201-500 Employees

Gubra is a biotech company built on three synergistic business units, Biotech, CRO Services, and Ventures, united by a commitment to scientific excellence, strong partnerships, and responsible impact. ESG principles are embedded in our business model, including Gubra Green, our subsidiary that allocates 10% of pre-tax profits to support a net-zero, nature-positive future.

Founded in 2008, Gubra has grown from a metabolic research specialist into a diversified organization of more than 300 scientists and experts. Today, we advance proprietary therapeutic programs, deliver high-end preclinical research services to global partners, and create new drug discovery opportunities through agile venture structures.

Our Biotech unit develops a growing pipeline of peptide-based therapeutics targeting metabolic diseases. Lead obesity programs include partnered assets ABBV-295 (a long-acting amylin analogue) and BI 3034701 (a triple agonist). Our internal lead candidate, GUB-UCN2, is a next-generation peptide for healthy weight loss now progressing in clinical development.

Our specialized preclinical CRO provides world-class capabilities across in vivo pharmacology, ex vivo assays, peptide chemistry, molecular pharmacology, histology, stereology, AI-enhanced imaging, and bioinformatics. Gubra is recognized for deep expertise in metabolic diseases and for highly translatable preclinical models.

Through Gubra Ventures, we develop high-potential science with clear translational hypotheses. Focusing on novel modalities in our core therapeutic areas, we target high-value disease segments where our peptide expertise creates competitive advantage. These focused, flexible structures enable promising programs to progress rapidly while staying closely connected to our scientific foundation.

Guided by science, speed, and a commitment to doing business in the best way for people and the planet, we bring together biotech innovation, world-class research, and entrepreneurial venturing.

Section iconCompany Overview

Headquarters
Denmark
Phone number
Website
gubra.dk
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
GUBRA.CO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $10M$25M

    Gubra's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Gubra's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.